Ron combines extensive business management and investment experience. Ron has an industrial chemistry background with Glaxo and Wilkinson Match/Sword Ltd. In the venture capital sector he was responsible for directing   a range of technology investments and served on the Board of six companies, managing a portfolio then valued at £23  million and including the quoted biotechnology companies AxisShield, British Biotechnology, PPL and Kone Labmedics Ltd. He then became the Managing Director of PPL Therapeutics plc, managing that company’s growth from a VC backed start up to an international quoted company with over 150 staff. He has also been a business advisor to Scottish Enterprise and Chairman of Biopta Ltd. and AquaPharm Bio-Discovery Ltd.. He is now also a Non-Executive Director for Haemostatix Ltd.. Ron brings to Parkure proven skills in all aspects of growing a business, investor relations, stock exchange listing and commercial collaboration with major pharmaceutical companies. Ron combines extensive business management and investment experience. Ron has an industrial chemistry background with Glaxo and Wilkinson Match/Sword Ltd. In the venture capital sector he was responsible for directing   a range of technology investments and served on the Board of six companies, managing a portfolio then valued at £23  million and including the quoted biotechnology companies AxisShield, British Biotechnology, PPL and Kone Labmedics Ltd. He then became the Managing Director of PPL Therapeutics plc, managing that company’s growth from a VC backed start up to an international quoted company with over 150 staff. He has also been a business advisor to Scottish Enterprise and Chairman of Biopta Ltd. and AquaPharm Bio-Discovery Ltd.. He is now also a Non-Executive Director for Haemostatix Ltd.. Ron brings to Parkure proven skills in all aspects of growing a business, investor relations, stock exchange listing and commercial collaboration with major pharmaceutical companies.

fermentation